Skip to content

Capricor Therapeutics CAPR Prepaid & Other Current

Prepaid & Other Current at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$187.97M+78.2%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$66.05M+15.8%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$7.53M-61.2%
Vericel logo
VericelVCEL
$7.99M-6.2%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$48.87M+307%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$22.56M+9.5%

Other financials

Income statement

See full
Revenue--100%
Operating income-$36.8M-47.2%
Net income-$33.9M-39.2%
EPS (diluted)-$0.59-11.3%

Balance sheet

See full
Cash & equivalents$105.4M+266%
Total debt$14.8M+1,083%
Total equity$278.7M+118%
Total assets$326.3M+112%

Cash flow

See full
Operating cash flow-$29.3M-355%
CapEx$5.1M+472%
Free cash flow-$34.4M-369%

Valuation

See full
Market cap$1.71B+303%
Enterprise value$1.62B+308%

Profitability

See full
Operating margin-778.8%-1,038pp
Net margin-736.6%-981pp
FCF margin-563.9%-954pp

Returns & leverage

See full
Return on equity-56.4%-11.3pp
Debt / equity0.1×0.0×
Current ratio8.4×+1.9×

Where this comes from

Reported directly by Capricor Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Capricor Therapeutics's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Capricor Therapeutics's prepaid & other current?
Capricor Therapeutics (CAPR) reported prepaid & other current of $4.48M in Q1 2026.
How has Capricor Therapeutics's prepaid & other current changed year-over-year?
Capricor Therapeutics's prepaid & other current increased by 216.8% year-over-year, from $1.41M to $4.48M.
What is the long-term trend for Capricor Therapeutics's prepaid & other current?
Over 5 years (2020 to 2025), Capricor Therapeutics's prepaid & other current has grown at a 36.3% compound annual growth rate (CAGR), from $1.01M to $4.75M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.